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Alternative splicing in eukaryotes plays an important role in regulating gene expression by
selectively including alternative exons. A wealth of information has been accumulated that
explains how alternative exons are selected in a developmental stage- or tissue-speciﬁc
fashion. However, our knowledge of how cells respond to environmental changes to alter
alternative splicing is very limited. For example, although a number of alternative exons
have been shown to be regulated by calcium level alterations, the underlying mechanisms
are not well understood. As calcium signaling in neurons plays a crucial role in essential
neuronal functions such as learning and memory formation, it is important to understand
how this process is regulated at every level in gene expression. The signiﬁcance of the
dynamic control of alternative splicing in response to changes of calcium levels has been
largely unappreciated. In this communication, we will summarize the recent advances in
calcium signaling-mediated alternative splicing that have provided some insights into the
important regulatory mechanisms. In addition to describing the cis-acting RNA elements
on the pre-mRNAmolecules that respond to changes of intracellular calcium levels, we will
summarize how splicing regulators change and affect alternative splicing in this process.
We will also discuss a novel mode of calcium-mediated splicing regulation at the level of
chromatin structure and transcription.
Keywords: alternative splicing, depolarization, RNA-binding proteins, chromatin, histone modification, transcrip-
tional elongation
Calcium signaling plays a pivotal role in many functions of the
cell at the molecular level. It is particularly important in neu-
rons for expression of genes essential for learning and memory
formation, and disruption of calcium signaling can cause neu-
ronal cell death leading to loss of memory (reviewed inWest et al.,
2001; Berridge, 2009). In neurons, changes in intracellular cal-
cium levels cause changes in membrane potential that control
neuronal excitability (reviewed in Berridge, 1998). Many stud-
ies have demonstrated that calcium signaling can regulate gene
expression at the transcription level (reviewed in Zhang et al.,
2009; Alonso and Garcia-Sancho, 2011). However, a number of
recent studies are revealing an intriguing new post-transcriptional
level of regulation by calcium signaling: at the level of alternative
pre-mRNA splicing. It has been observed that an alteration of the
intracellular calcium level can lead to differential expression of
numerous alternative exons (reviewed in Xie, 2008). These obser-
vations have very signiﬁcant implications in terms of the dynamic
control of alternative splicing.
More than 95%of the protein-coding genes in humans undergo
alternative splicing to provide a varied proteome (Pan et al., 2008;
Wang et al., 2008). Studies carried out during the last three decades
have generated a wealth of information that contributes to our
understanding of cell type- and developmental stage-speciﬁc reg-
ulation of alternative splicing.However,we know surprisingly little
about howcells respond to stimuli tomodulate alternative splicing.
Only a handful of studies have explored the underlying mecha-
nisms by which calcium signaling regulates alternative splicing.
A review published in 2008 provided a comprehensive summary
of calcium-mediated splicing control (Xie, 2008). In this review,
the author compiled a list of nearly 20 alternative exons that were
demonstrated to undergo calcium-mediated regulation. Next, he
discussed the potential mechanisms of calcium-mediated splicing
control using three well-studied examples. Finally, he speculated
how calcium signaling inﬂuences neuronal functions and dis-
ease development. Since 2008, several more studies have been
published, one of which demonstrated an exciting new level of
regulation. The current review is aimed at providing an in-depth
discussion of themolecularmechanisms of the dynamic control of
alternative splicing regulated by calcium signaling. An important
goal is to draw attention to this under-explored area of research.
Building on information gained from a limited number of studies,
we will point out important future directions.
REGULATION OF ALTERNATIVE SPLICING
Production of protein-coding mRNAs in mammalian cells
involves two tightly coupled processes: transcription of the pre-
mRNA from the gene and pre-mRNA processing, which consists
of 5′ end capping, removal of introns, and polyadenylation of the
3′ end of the pre-mRNA. RNA processing factors are loaded onto
the pre-mRNA co-transcriptionally, some through the C terminal
domain (CTD) of the largest subunit of RNA polymerase II (RNA
Pol II) (Misteli and Spector, 1999; Hirose andManley, 2000; Lewis
and Tollervey, 2000; Phatnani et al., 2004; Rosonina and Blencowe,
2004; Bentley, 2005; Egloff and Murphy, 2008). The classical view
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of alternative splicing regulation involves short conserved RNA
sequences (enhancers and silencers) found in exons and introns
of the pre-mRNA molecule, where splicing regulators such as
serine/arginine proteins (SR proteins) and heterogeneous ribonu-
cleoproteins (hnRNPs) bind (reviewed in Black, 2003; Jurica and
Moore, 2003). Upon binding to an enhancer or silencer sequence,
the splicing regulators either recruit the spliceosome, the basal
splicingmachinery, to or prevent the spliceosome from interacting
with a particular splice site to regulate the associated alternative
exon. Many splicing regulators are tissue-speciﬁc and hence are
thought to be important in providing developmental stage-speciﬁc
and functional isoforms of proteins for a particular tissue (Black,
2003; Grosso et al., 2008).
In addition to regulation by splicing factors, alternative splicing
can be controlled by the rate of transcription as was ﬁrst shown by
cell transfection experiments. A change in the rate of RNA synthe-
sis provides a change in the secondary structure of the pre-mRNA,
which in turn affects the splicing event (Eperon et al., 1988). This
was conﬁrmed when different levels of alternative exon inclusion
were observed for the same gene using promoters of different
strengths to drive transcription. To explain the effects on alter-
native splicing by transcription, two models have been proposed
in the literature: the recruitment model and the kinetic coupling
model. The recruitmentmodel suggests that splicing regulators are
recruited to pre-mRNA through their association with the tran-
scription machinery, in particular the CTD of Pol II, to regulate
splicing choices, whereas the kinetic model suggests that splicing
is controlled by the rate of elongation of Pol II. The slower rate of
transcription elongation allows more time for the usage of weak
splice sites (reviewed in Kornblihtt, 2005; Allo et al., 2011; Luco
et al., 2011).
The rate of elongation of transcription is thought to be con-
trolled by chromatin structure and the level of compaction of
the intragenic regions. The following recent studies support an
emerging idea that chromatin structure and histone modiﬁca-
tions are major contributors in regulation of alternative splicing
events (Allo et al., 2011; Luco et al., 2011). First, nucleosomes
were found to be enriched on exons as compared to introns by
analysis using the deep sequencing technique in combination with
computational predictions (reviewed in Kaplan, 2009; Kornblihtt
et al., 2009; Schor et al., 2010). The general hypothesis is that the
nucleosomes provide a “roadblock or speed bump” for RNA Pol
II elongation, which in turn provides more time for the splic-
ing machinery to recognize alternative exons (Allo et al., 2011;
Luco et al., 2011). In addition to the exon deﬁnition concept
(Berget, 1995), where the splicing machinery recognizes intron–
exon boundaries by physically interacting with the splice sites, this
is thought to provide anothermode of control at the DNA level for
splice site recognition. Support for this hypothesis came from the
observation that there is an enrichment of RNA Pol II at alterna-
tively spliced exons in comparison to constitutive exons, thereby
providing the splicing machinery more time to access weak splice
sites present at the alternative splice sites (Brodsky et al., 2005).
Secondly, chromatin immunoprecipitation (ChIP) studies
indicate that exons are differentially marked with speciﬁc his-
tone modiﬁcations such as trimethylation of lysine 36 of histone 3
(Kolasinska-Zwierz et al., 2009; Spies et al., 2009). Thirdly, studies
have demonstrated that speciﬁc histone marks can recruit splicing
factors to the transcription site. For example, H3K4me3 recruits
the U2 snRNP, a component of the spliceosome, via the CHD1
protein that interacts with the histone mark (Sims et al., 2007). In
addition, H3K9me3 recruits hnRNPs through the HP1 proteins
in Drosophila (Piacentini et al., 2009). These studies indicate that
histone modiﬁcations can have a direct impact on splicing factor
recruitment. Lastly, a very recent study indicates that Hu pro-
teins, upon binding to their target sequences on the pre-mRNA,
inﬂuence the acetylation status of histones H3 and H4 leading
to a localized change in transcription elongation rate that further
impacts exon skipping of at least two alternative exons (Zhou et al.,
2011).
CALCIUM AND SPLICING
Several studies have shown that disturbance of the physiolog-
ical balance of calcium can contribute to alterations of alter-
native splicing events, especially in neuronal cells which have
the most diverse RNA population (Xie and Black, 2001; Black
and Grabowski, 2003; An and Grabowski, 2007; Lee et al., 2007;
Schor et al., 2009). In each of these studies, depolarization was
induced in cells with introduction of high extracellular potassium,
which triggers calcium signaling by opening voltage-dependent
calcium channels (Figure 1). An increase in internal calcium level
causes skipping of exon 5 and exon 21 of NMDA receptor type
1 (NMDAR1) in hippocampal neurons (Han et al., 2005; An and
Grabowski, 2007; Lee et al., 2007) as well as the STREX exon of the
FIGURE 1 | Stimulation of a cell using various drugs can increase or
decrease intracellular calcium by affecting various channels and
pumps associated with calcium influx. Increase in intracellular calcium
activates calcium/calmodulin-dependent kinases, which inﬂuence splicing
and/or localization of several splicing factors. These splicing factors can in
turn regulate splicing by binding to CaRREs or UAGG motifs in the
pre-mRNA. In addition, CaMK can phosphorylate protein kinases A and C,
which feed into the downstream MAPK pathway, eventually
phosphorylating ERK. Phosphorylated ERK plays a role in hyperacetylation
of histones H2B, H3, and H4, which affects splicing by controlling the rate
of transcription. CaMK also increases trimethylation of histone H3K36 at
speciﬁc exons, although the mechanism by which CaMK does it is not
known. The increase in trimethylation of histone H3K36 can directly affect
splicing by recruiting splicing factors.
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BK channel in GH3 pituitary cells (Xie and Black, 2001). These
two splicing events, which are regulated by calcium signaling, have
been studied in much detail and the results have provided impor-
tant insights into how splicing regulation by calcium signaling can
inﬂuence neuronal functions and diseases (Xie, 2008). In the case
of the STREX exon of the BK channel, the regulated inclusion of
the exon is thought to ﬁne-tune the electrical activity of neurons
(Xie, 2008). It has been shown that inclusion of the exon increases
the sensitivity of theBKchannels to voltage and calcium,providing
a feedback loop regulatory mechanism (Li et al., 2007, 2009; Xie,
2008; and references therein). In the case of NMDAR1, the inclu-
sion or exclusion of exons 5 and 21 affects the localization and
membrane trafﬁcking of the NMDA receptor. This localization
and trafﬁcking in turn regulates the synaptic strength to stabilize
the neuronal ﬁring rate (homeostatic plasticity in neurons) (Lee
et al., 2007; Li et al., 2007; and references therein).
Treatment of neurons by various drugs increases intracellular
calcium levels by affecting calcium channels and pumps. Agonists
of NMDA receptors, such as NMDA, and glutamate can increase
calcium inﬂux through the NMDA receptors, whereas antago-
nists such as MK801 can inhibit the inﬂux of calcium through
NMDA receptors. Opening of L-type calcium channels can be
inhibited by use of pharmacological agents such as nifedipine,
nimodipine, and verapamil (Xie, 2008; Yoneyama et al., 2011;
Figure 1). Thapsigargin increases intracellular calcium by inhibit-
ing the sarco/endoplasmic reticulum calcium pump, whereas use
of dantrolene can inhibit the release of the calcium from the
sarco/endoplasmic reticulum (Yoneyama et al., 2011) (Figure 1).
In addition to these two genes, it has been shown that increas-
ing calcium in the cell by using any of these pharmacological
agents affects the changes in splice site selection for many genes
(for a complete list see Table 1 in the review by Xie, 2008). Also,
an exon-array performed on human neuroblastoma IMR-32 cells
after depolarization with potassium chloride at different time
points or after treatment with thapsigargin identiﬁed a number
of genes that showed changes in splicing and transcript levels.
Splicing changes were observed in mRNAs of genes such as potas-
sium channels, neuroendocrine secretory proteins and metabolic
enzymes (McKee et al., 2007).
CALCIUM AND RNA ELEMENTS
It is thought that just like the RNA elements in exons and introns
where speciﬁc splicing regulators bind to regulate the inclusion
or skipping of the exon, there are speciﬁc short conserved RNA
sequences under the regulation of calcium. The current working
theory is that increased intracellular calcium levels result in the
activation of calcium/calmodulin-dependent kinase IV (CaMK
IV), which regulates splice site selection through speciﬁc RNA ele-
ments namedCaMKIV responsiveRNAelements (CaRREs) (Ares,
2007; Lee et al., 2007; Xie, 2008). Two such CaRRE sequences,
CACAUNRUUAU (N: any nucleotide, R: purine) and GUG-
GUAGA, have been identiﬁed (Xie et al., 2005; Lee et al., 2007; Xie,
2008). Importantly, when these CaRREs were inserted into amini-
gene reporter, the mini-gene alternative splicing was regulated by
CaMK IV activity (Xie and Black, 2001; Xie et al., 2005; Lee et al.,
2007). Other than the CaRREs, a distinct UAGG motif in the pre-
mRNAhas been shown tobe required for depolarization-mediated
splicing regulation. The UAGG motif-mediated splicing regula-
tion can be inhibited by KN93, a calcium/calmodulin-dependent
kinase inhibitor (An and Grabowski, 2007). In addition, KN93
and nifedipine, an L-type calcium channel blocker, were shown
to block the exclusion of the STREX exon (thought to be under
CaRRE control) caused by potassium chloride-mediated depolar-
ization (Xie and Black, 2001; Xie et al., 2005). Lastly, cerebella
of CaMK IV heterozygous mice showed increased STREX exon
inclusion (Xie et al., 2005).
The mechanism by which CaMK IV inﬂuences speciﬁc RNA
elements still remains an open question. One theory is that an
increase in the calcium level activates CaMK IV, which eventu-
ally regulates splicing through these speciﬁc RNA elements in the
pre-mRNA (CaRREs and UAGG). This is supported by the fact
that the observed changes in splicing after increases in the intra-
cellular calcium level can be inhibited in most of these cases by
the use of either CaMK inhibitors or by other inhibitors that
affect calcium levels in the cell [for a complete list see Table 1,
Xie, 2008)]. Although the detailed molecular mechanisms remain
largely unknown on how CaMK levels inﬂuence splicing through
the CaRRE RNA elements, a hint came from the studies of the
UAGG motifs. In this case, hnRNP A1 was found to bind to these
speciﬁc motifs in pre-mRNA and eventually inﬂuence splice site
selection in neurons (An and Grabowski, 2007). Subsequent stud-
ies demonstrated that hnRNP L is the splicing factor that binds to
a CaRRE RNA element inﬂuencing splice site selection (Yu et al.,
2009). This regulation of hnRNP L on the CaRRE1 RNA elements
was further shown to be dependent on phosphorylation of hnRNP
L, which can be induced by CaMK IV as shown in in vitro assays
using hnRNP L and CaMK IV puriﬁed frommammalian cells (Yu
et al., 2009). A SELEX analysis indicated that a “CA” repeat motif
is sufﬁcient for the CaMK IV-mediated regulation of alternative
splicing through hnRNP L (Li et al., 2009).
Interestingly, the CaMK IV-hnRNP L cascade may also modu-
late alternative splicing of a non-neuronal gene, CD45 (PTPRC).
Alternative splicing of the CD45 transcript is tightly regulated dur-
ing B cell development. In early peripheral lymphocytes, exons 4, 5,
and 6 are included,while at later stages of B cell development, none
of the three exons are included (Ogimoto et al., 1993). Several stud-
ies demonstrated that splicing regulation of exons 4 and 6 is medi-
ated by hnRNP L, polypyrimidine tract-binding protein (PTB)-
associated splicing factor (PSF), and hnRNP LL (Melton et al.,
2007; Topp et al., 2008). Treatment of early stages of B cells with
ionomycin, an ionophore which increases intracellular calcium,
led to skipping of all of these alternative exons (Ogimoto et al.,
1993). It remains to be determined whether there exist CaRRE
elementswhere hnRNPLcouldpotentially bind and regulate splic-
ing of these exons. However, an exonic splicing silencer (ESS) that
has been identiﬁed to be bound by hnRNP L and PSF is indeed
CA-rich, similar to the CaRRE elements (Melton et al., 2007).
It is highly likely that many additional calcium responsive RNA
elements remain to be identiﬁed. The recently developed high-
throughput technologies will undoubtedly be very helpful in this
regard. Presumably, these elements are under the inﬂuence of cal-
cium signaling and can be bound by different splicing regulators
in regulation of the expression of the alternative exons with which
they are associated (Figure 1).
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CALCIUM AND SPLICING FACTORS
How does calcium signaling inﬂuence the expression of splicing
regulators themselves? Recent studies appear to reveal a theme for
this regulation. Changes in calcium levels regulate cellular localiza-
tion of a number of RNA-binding proteins (RBPs). For example,
cortical neurons depolarized by treatment with potassium chlo-
ride were shown to have an increased localization of the splicing
factor hnRNPA1 in the nucleus (An and Grabowski, 2007). Inter-
estingly, for a number of RBPs, the change in cellular localization
is the consequence of regulated alternative splicing. A clear exam-
ple is Fox-1/A2BP1, where exon 19 inclusion is repressed when
neuronal cells are depolarized by potassium chloride (Lee et al.,
2009). The skipping of exon 19 causes a frame shift in the protein,
which leads to a more nuclear localization of Fox-1/A2BP1 pro-
tein (Lee et al., 2009). Recently, a genome-wide analysis of mice
with a central nervous system-speciﬁc gene depletion of Rbfox1
(A2BP1) revealed splicing changes in multiple transcripts that
encode proteins important for synaptic functions and neuronal
excitation (Gehman et al., 2011). Another example is exon III
of the Tra2beta1 transcript, which appears to be a more com-
plicated story. When rats were treated with pilocarpine, a drug
that functions as an agonist of muscarinic acetylcholine receptor
and elevates calcium levels in the cell, complex results that are
suggestive of a cell-speciﬁc differential response to calcium level
changes were obtained. The treatment led to a reduced inclusion
of exon 3 of Tra2beta1 in the hippocampus and increased inclu-
sion in the brain cortex (Daoud et al., 1999). In a subsequent study
from the same group, it was shown that treatment of primary cor-
tical neurons with thapsigargin as well as pilocarpine increased
accumulation of the Tra2beta1 protein in the cytoplasm (Daoud
et al., 2002). Furthermore, translocation of Tra2beta1 to the cyto-
plasm was also observed in ischemic induction, which increases
the intracellular calcium levels. Interestingly, these treatments led
to splicing changes of a downstream target (Daoud et al., 2002).
Taken together, these studies strongly suggest that alterations in
intracellular calcium levels may alter the localization of many of
the spliceosomal components in neurons. Such changes can lead
to alterations in splice site selection of downstream target genes
that are regulated by these splicing factors.
Splicing change as a result of altered calcium level was also
observed with transcripts of other splicing factors. However, in
these cases, it is not clear if altered splicing leads to localiza-
tion changes of the resulting proteins. Intron 6 in the pre-mRNA
encoding Ania-6 (cyclin L1) was shown to be retained when cal-
cium levels were increased with the use of glutamate in striatal
neurons. Paradoxically, potassium chloride depolarization that
also increases calcium levels led to less intron retention (Berke
et al., 2001; Sgambato et al., 2003). Furthermore, exon 3 of hnRNP
H3 and exon 2 of RNP-S1 were shown to be skipped when cor-
tical neurons were depolarized by potassium chloride (An and
Grabowski, 2007).
CALCIUM LEVELS AFFECT SPLICING BY REGULATING
CHROMATIN MODIFIERS
Recently, various studies have indicated that calcium signaling can
inﬂuence chromatin modiﬁcation, which in turn inﬂuences splice
site selection. For example, an increase in intracellular calcium
by depolarization using potassium chloride induces acetylation
of H2B in the hippocampus of rats (Maharana et al., 2010). The
elevated level of acetylation is reversed by addition of KN93, a
CaMK inhibitor, suggesting that the acetylation of H2B requires
CaMK (Maharana et al., 2010). The acetylation of H2B is also
blocked by U0126, a speciﬁc inhibitor targeting ERK phosphory-
lation, suggesting that the increased acetylation is dependent on
ERK phosphorylation. ERK is a known target for phosphoryla-
tion by CaMK; however, the mechanism by which ERK acetylates
H2B remains unknown (Maharana et al., 2010). Furthermore,
the treatment of rat hippocampal neurons with NMDA increases
calcium inﬂux, and activates the protein kinase A (PKA) or pro-
tein kinase C (PKC) pathway, which enhances ERK-dependent
acetylation of Histone H3 (Levenson et al., 2004; Chandramohan
et al., 2008). These data suggest that an increase in intracellu-
lar calcium levels can inﬂuence the acetylation levels of histones
(Figure 1).
Changes of acetylation levels of histones by intracellular cal-
cium signaling may lead to splicing pattern changes. It has been
shown that cells treated with trichostatin A (TSA), a potent
inhibitor of histone deacetylation, exhibit changes in mini-gene
splicing (Nogues et al., 2002). In addition, studies carried out using
yeast indicate that hyperacetylation of H3 by histone deacetylase
(HDAC) depletion can delay the release of U2 snRNP, and per-
turb the assembly of spliceosome components (Gunderson et al.,
2011). Recently an exon-array study showed that in HeLa cells
treated with sodium butyrate (NaB), a potent HDAC inhibitor,
683 genes showed changes in splice site selection, including Tau,
which is expressed in the central nervous system and associated
with fronto-temporal dementia andParkinson’s disease (Hnilicova
et al., 2011).
Depolarizationbypotassiumchloride induces hyperacetylation
of histones H3 and H4 globally in N2A cells and this hyper-
acetylation is reversed when cells are treated with normal media
suggesting that global hyperacetylation is a direct consequence of
increased intracellular calcium (Schor et al., 2009). This depo-
larization and recovery coincide with the alternative splicing of
NCAM exon 18, which is skipped when cells are depolarized and
included after recovery (Schor et al., 2009). ChIP studies showed
an increase inH3K9ac in the intragenic chromatin region between
exons 17 and 19 in response to depolarization (Schor et al., 2009).
These data suggest that hyperacetylation of histones in response to
increases in calcium affects the splice site selection of exon 18. This
idea was further supported by the use of TSA,whichmimicked the
results of depolarization (Schor et al., 2009).
H3K36-Me3 marks have been shown to differ at constitutive
and alternative exons. H3K36-Me3 marks are found at the 5′ ends
of the exons and enrichment of these methyl marks correlates
with increases in alternative exon inclusion (Hon et al., 2009;
Kolasinska-Zwierz et al., 2009). H3K36-Me3 can recruit PTB, a
splicing regulator, to the pre-mRNA through the chromatin bind-
ing protein MRG15 (Luco et al., 2010). Recruitment of splicing
machinery at a weak alternative splice site assists in the inclusion
of the weak exon (Allo et al., 2011; Luco et al., 2011). Calcium sig-
naling could also affect methylation of this histone mark, as it was
shown that depolarization by potassium chloride also increases
H3K36-Me3 at distal exons of the NCAM gene in hippocampal
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neurons, but the mechanism by which calcium signaling achieves
this is not clear (Schor et al., 2009).
Data obtained from these studies indicate that an increase in
calcium signaling could affect chromatin modiﬁcations, which
may inﬂuence alternative splicing. It is tempting to speculate that
in addition to the direct effects on RBPs, this might be another
mechanism by which calcium regulates alternative splicing in
neurons indirectly (Figure 1).
An intriguing new study demonstrates that exon 5 splicing of
CD45 pre-mRNA is modulated during development as a conse-
quence of chromatinmodiﬁcation (Shukla et al., 2011). This study
shows that CTCF, a zinc-ﬁnger DNA binding protein, binds to the
exon 5 region of the CD45 gene, slowing down transcription by
providing a pausing of RNAPol II. This allows for exon 5 inclusion
at the early stages of lymphocyte development. During matura-
tion of lymphocytes, CTCF binding is perturbed due to increased
methylation on DNA in a region where CTCF binds to exon 5,
leading to exon 5 skipping (Shukla et al., 2011). Given that expres-
sion of exon 5 of CD45 was shown to respond to cellular calcium
level changes, it will be interesting to investigate whether calcium
signaling affects the methylation status of DNA at exon 5, thereby
modulating the splicing of exon 5 of the CD45 pre-mRNA.
PERSPECTIVE
All of the studies discussed above point in the direction that
changes in calcium signaling can play a major role in alternative
splicing in neurons and other cell types. This could possibly
be a molecular mechanism by which cells control the dynamic
expression of exons that are important for their development
and function. The calcium levels in neurons are under “home-
ostatic control” and disruption of the normal calcium level in
neurons leads to disruption of neuronal functions and disease
development (reviewed in Marambaud et al., 2009). Genome-
wide exon arrays are now available and could be a useful tool
in identifying the groups of genes whose alternative splicing is
regulated by calcium signaling. With the advent of newer tech-
niques like deep sequencing and genome-wide siRNA libraries
with the augmentation of bioinformatic tools, it is time to study
the effect of calcium-regulated alternative splicing and its role
in physiological development and disease states at the genome-
wide level. It is conceivable that expression of many alternative
exons is subject to calcium signaling and that the dynamic reg-
ulation of these exons involves numerous distinct RNA elements
and RBPs that interact with these RNA elements. Rules of cal-
cium signaling-regulated alternative splicing will emerge from
genome-wide studies.
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